Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 2
|
pubmed:dateCreated |
1992-5-4
|
pubmed:abstractText |
Using intravital microscopy, we compared the responses to serotonin [5-hydroxytryptamine (5-HT)] and to a specific 5-HT2 agonist [1-(2,5-dimethoxy-4-bromo-phenyl)-2-aminopropane (DOB)] by normal arterioles and by the host-modified arterioles feeding a Meth A tumor implanted into the flank of female BALB/c mice. Topical and intravenous administration of 5-HT (10(-6) to 10(-4) M and 0.01-10 micrograms) or DOB (5 x 10(-7) to 5 x 10(-5) M and 0.01-10 micrograms) induced arteriolar constriction, which was far more pronounced for the arterioles feeding the tumor. This larger degree of vasoconstriction in tumor-feeding vs. normal arterioles was not found with norepinephrine. We also compared tumor growth and the mouse life span in three groups of mice, which were given 1 mg of serotonin or 0.74 mg DOB or saline solution. 5-HT or DOB both reduced tumor growth drastically compared with the controls (P less than 0.001), and survival rates were significantly higher in the 5-HT or DOB-treated groups (P less than 0.001). We conclude that 5-HT2-serotoninergic agonists are of particular pharmacological interest, since their vasoconstrictive action on the microvasculature feeding the tumors is much greater than in normal tissue and may interfere with tumor growth.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,5-Dimethoxy-4-Methylamphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/2,5-dimethoxy-4-bromoamphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
262
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H704-9
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1558179-2,5-Dimethoxy-4-Methylamphetamine,
pubmed-meshheading:1558179-Analysis of Variance,
pubmed-meshheading:1558179-Animals,
pubmed-meshheading:1558179-Arterioles,
pubmed-meshheading:1558179-Cell Division,
pubmed-meshheading:1558179-Dose-Response Relationship, Drug,
pubmed-meshheading:1558179-Fibrosarcoma,
pubmed-meshheading:1558179-Mice,
pubmed-meshheading:1558179-Mice, Inbred BALB C,
pubmed-meshheading:1558179-Muscle, Smooth, Vascular,
pubmed-meshheading:1558179-Norepinephrine,
pubmed-meshheading:1558179-Receptors, Serotonin,
pubmed-meshheading:1558179-Reference Values,
pubmed-meshheading:1558179-Sarcoma, Experimental,
pubmed-meshheading:1558179-Serotonin,
pubmed-meshheading:1558179-Skin
|
pubmed:year |
1992
|
pubmed:articleTitle |
Specific esponse to 5-HT2 agonists by arterioles linked to Meth A tumors in mice.
|
pubmed:affiliation |
Department of Biophysics, Hôpital F. Widal, Paris, France.
|
pubmed:publicationType |
Journal Article
|